Corteva, Inc. $CTVA Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 3.0% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,903,828 shares of the company’s stock after purchasing an additional 113,564 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Corteva were worth $330,615,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in CTVA. Brighton Jones LLC grew its holdings in Corteva by 307.2% in the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock valued at $888,000 after buying an additional 11,760 shares during the period. Woodline Partners LP boosted its position in shares of Corteva by 40.3% in the first quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock worth $3,645,000 after acquiring an additional 16,644 shares during the last quarter. EverSource Wealth Advisors LLC grew its holdings in Corteva by 62.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock valued at $191,000 after purchasing an additional 980 shares during the period. Cresset Asset Management LLC grew its holdings in Corteva by 2.6% in the second quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock valued at $526,000 after purchasing an additional 181 shares during the period. Finally, Jump Financial LLC acquired a new position in Corteva during the second quarter worth approximately $1,464,000. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Price Performance

Corteva stock opened at $84.74 on Tuesday. The firm has a fifty day moving average of $82.81 and a 200-day moving average of $80.66. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $90.97. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. The firm has a market capitalization of $56.54 billion, a P/E ratio of 56.12, a PEG ratio of 2.58 and a beta of 0.57.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The firm had revenue of $6.38 billion during the quarter, compared to analysts’ expectations of $6.60 billion. During the same period in the prior year, the company earned $2.20 EPS. The firm’s revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, analysts predict that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be paid a $0.18 dividend. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.8%. Corteva’s dividend payout ratio (DPR) is 47.68%.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the stock. UBS Group decreased their price target on shares of Corteva from $89.00 to $85.00 and set a “neutral” rating on the stock in a report on Tuesday, August 18th. Jefferies Financial Group upped their price objective on Corteva from $95.00 to $97.00 in a report on Thursday, May 7th. BMO Capital Markets increased their target price on Corteva from $95.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday, August 3rd. Mizuho boosted their price target on Corteva from $96.00 to $97.00 and gave the company an “outperform” rating in a research report on Tuesday, July 14th. Finally, Weiss Ratings downgraded Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, August 3rd. Fourteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $91.50.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.